A Phase II Clinical Trial of Efficacy and Safety of SAL0140 at Different Doses in Patients With Chronic Kidney Disease
Clinical trial NCT07647133 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07647133
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2027-10-08
- Enrollment
- 249
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.